Correction: Ingles Markets Swings to Loss in Fiscal Q4, Revenue Declines-March 2024-www.financetom.com

Correction: Ingles Markets Swings to Loss in Fiscal Q4, Revenue Declines

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Correction: Ingles Markets Swings to Loss in Fiscal Q4, Revenue Declines

Dec 27, 2024 5:55 AM

08:24 AM EST, 12/27/2024 (MT Newswires) -- (Corrects revenue figures in the second paragraph.)

Ingles Markets ( IMKTA ) reported a fiscal Q4 loss Friday of $0.08 per diluted share, swinging from net income of $2.77 a year earlier.

Net sales for the quarter ended Sept. 28 were $1.4 billion, down from $1.58 billion a year earlier.

Analyst estimates were not available.

Shares of Ingles Markets ( IMKTA ) were up 1.3% in recent premarket activity.

Previous page： JPMorgan profit drops as loan loss provisions eclipse investment banking Next page： --Wells Fargo Reports Q3 EPS of $1.42, Down From $1.48 Year Ago

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

JPMorgan profit drops as loan loss provisions eclipse investment banking

Oct 11, 2024

(Reuters) -JPMorgan Chase's ( JPM ) profit dropped in the third quarter as a bigger provision for potential loan defaults offset gains from investment banking, the bank said on Friday. Banks are building up stockpiles - which act as a safeguard when borrowers default on their loans - to typical levels as consumers deplete the savings they built up during...

--Wells Fargo Reports Q3 EPS of $1.42, Down From $1.48 Year Ago

Oct 11, 2024

06:54 AM EDT, 10/11/2024 (MT Newswires) -- Price: 57.25, Change: -0.50, Percent Change: -0.87 ...

Bank of New York Mellon Q3 Adjusted Earnings, Revenue Rise; Declares Dividend

Oct 11, 2024

06:52 AM EDT, 10/11/2024 (MT Newswires) -- Bank of New York Mellon ( BK ) reported Q3 adjusted earnings Friday of $1.52 per diluted share, up from $1.27 a year earlier. Analysts polled by Capital IQ expected $1.42. Total revenue for the quarter ended Sept. 30 was $4.65 billion, up from $4.42 billion a year earlier. Analysts surveyed by Capital...

Turnstone Biologics Cuts Workforce by 60% to Focus on Phase 1 Cancer Program

Oct 11, 2024

06:55 AM EDT, 10/11/2024 (MT Newswires) -- Turnstone Biologics ( TSBX ) said Friday it reduced about 60% of its workforce and changed its leadership team as part of a restructuring initiative. The company said the restructuring would help it focus its resources on the continued development of its phase 1 cancer program, TIDAL-01. The restructuring initiatives are expected to...